|
All Business Categories
|
AlphaRx Inc.
Ontario, Canada AlphaRx is developing several drug products in the therapeutic categories of Osteoarthritis and Infectious Disease. AlphaRx intends to file IND and NDA submissions with the FDA (wh... IntraBiotics Pharmaceuticals , Inc. California, USA Developing biopharmaceutical products for the prevention and treatment of serious and life-threatening infections. Sirtris Pharmaceuticals Inc. Massachusetts, USA Sirtris PharmaceuticalsÔ is a biopharmaceutical company developing novel therapeutics that modulate sirtuins. Sirtris has the leading sirtuin intellectual property estate and know-... BioDelivery Sciences International , Inc. North Carolina, USA We are a specialty pharmaceutical company that is exploiting our licensed and proprietary patented drug delivery technologies to develop and commercialize, either on our own or in ... Cellular Genomics Inc. Connecticut, USA Cellular Genomics Inc. (CGI) is a privately held genomics-based biopharmaceutical company that is pioneering a highly integrated chemical genetics platform for drug discovery and d... CB24, United Kingdom CeNeS Pharmaceuticals plc (AIM: CEN), the biopharmaceutical company developing a new generation of pain management products, announces interim results for the six months ended 30 J... Vical Incorporated California, USA Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. P... VASTox plc Oxfordshire, United Kingdom VASTox is a chemical genomics technology company that provides services to the pharmaceutical industry and discovers and develops proprietary novel drugs. The company's technology ... Memory Pharmaceuticals Corp. New Jersey, USA Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, sc... The Avicena Group , Inc. California, USA The Avicena Group, Inc. (OTCBB: AVGO) is a late stage, revenue generating biotechnology company focused on developing products based on its proprietary understanding of the regulat...
First
Prev
[4]
[7]
[10]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21]
[22]
23
[24]
[25]
[26]
[27]
[28]
[29]
[30]
[31]
[32]
[749]
[1467]
[2184]
Next
Last
|
